Norges Bank
IMVT icon

Norges Bank’s Immunovant IMVT Stock Holding History

Norges Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-687,662
Closed -$11M – 750
2025
Q2 		$11M Buy
687,662
+49,715
+8% +$752K ﹤0.01% 1260
2025
Q1 		$10.9M Hold
637,947
– – ﹤0.01% 1268
2024
Q4 		$15.8M Buy
637,947
+74,253
+13% +$2.11M ﹤0.01% 1269
2024
Q3 		$16.1M Sell
563,694
-38,167
-6% -$1.13M ﹤0.01% 1265
2024
Q2 		$15.9M Sell
601,861
-54,239
-8% -$1.54M ﹤0.01% 1269
2024
Q1 		$21.2M Buy
656,100
+617,659
+1,607% +$22.5M ﹤0.01% 1246
2023
Q4 		$1.62M Buy
+38,441
New +$1.41M ﹤0.01% 1815
2023
Q1 		– Sell
-211,600
Closed -$3.76M – 2127
2022
Q4 		$3.76M Sell
211,600
-8,301
-4% -$105K ﹤0.01% 1859
2022
Q3 		$1.23M Buy
219,901
+190,435
+646% +$931K ﹤0.01% 1990
2022
Q2 		$115K Hold
29,466
– – ﹤0.01% 2046
2022
Q1 		$162K Hold
29,466
– – ﹤0.01% 2149
2021
Q4 		$251K Hold
29,466
– – ﹤0.01% 2185
2021
Q3 		$256K Sell
29,466
-408,300
-93% -$3.68M ﹤0.01% 2256
2021
Q2 		$4.63M Buy
437,766
+241,323
+123% +$3.37M ﹤0.01% 1918
2021
Q1 		$3.15M Buy
196,443
+182,074
+1,267% +$4.8M ﹤0.01% 1959
2020
Q4 		$664K Buy
+14,369
New +$664K ﹤0.01% 2064

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Norges Bank's IMVT Position: Q3 2025 in Review

Norges Bank sold out of Immunovant (IMVT) in Q3 2025, closing a stake of 687,662 shares — an estimated $11M sold.

Norges Bank first reported a position in IMVT in Q4 2020 and held it in 16 quarters. The position peaked at $21.2M in Q1 2024. 186 funds tracked by Wall St. Rank hold IMVT as of Q3 2025.

  • Norges Bank reported no remaining Immunovant position as of Q3 2025 after selling out during the quarter.
  • Norges Bank sold 687,662 Immunovant shares in Q3 2025, an estimated $11M.
  • Norges Bank first reported a position in Immunovant in Q4 2020 and held it in 16 quarters.
  • Norges Bank's Immunovant position peaked at $21.2M in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Immunovant as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.